Effects of an Augmented Reality Exercise Program in Older Adults
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-95
SponsorUniversidade da Madeira
About this trial
This research aims to examine the effects of an augmented reality (AR) exercise program on physical fitness (cardiorespiratory capacity, strength, balance, agility, and flexibility) and cognitive function (reaction time, decision-making, and memory).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants of both genders
60 years or older
Autonomous community-dwelling older adults
Disqualifiers
Neurological disorders
Cognitive impairment
Health limitations related to exercise participation
Trial design
Design model
Parallel
Treatments tested in this trial
Augmented reality exercise program
Other interventionParticipants enrolled in an organized exercise program based on two weekly sessions of 45 to 60 minutes each for 12 weeks: one traditional session (group session) and one augmented reality (AR) session (individual session), both supervised by sports and exercise professionals. The AR session was designed to provide an entire exercise session targeting physical fitness components (cardiorespiratory capacity, strength, balance, agility, and flexibility) and cognitive function (reaction time, decision-making, and memory).
Traditional exercise program
Other interventionParticipants enrolled in a traditional organized exercise program (group sessions) based on two weekly sessions of 45 to 60 minutes each for 12 weeks. These sessions are supervised by sports and exercise professionals, targeting physical fitness components (cardiorespiratory capacity, strength, balance, agility, and flexibility) and cognitive function (reaction time and decision-making).
Treatment groups
30 Participants
are divided into 3 treatment groupsGroup A: Control groupNo intervention 0 interventions
Group B: Traditional exercise programExperimental treatment 1 intervention
Group C: Augmented reality exercise programExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Physical fitness
Physical fitness will be assessed using the fitness test battery proposed by Rikli \& Jones (1999), including: 30-s chair stand test to assess lower-body strength, arm curl test to evaluate upper-body strength, back scratch test to examine upper-body flexibility, chair seat and reach test to assess lower-body flexibility, 8-foot up-and-go test to assess agility and dynamic balance, and the 6-min walk test to evaluate aerobic endurance.
Time frame
Testing sessions will occur at baseline, at week 6, at week 13 and at week 18.2
Physical activity
Physical activity levels will be measured using accelerometry during each exercise session.
Time frame
Participants enrolled in exercise programs will be monitored using accelerometry. Individual data will be collected in all exercise sessions (total of 48 sessions).3
Body composition
Body composition will be evaluated using the InBody 770, which allows a hand-to-foot biolectrical analysis. Bodyweight, body fat percentage, and fat-free mass will be used for analysis.
Time frame
Testing sessions will occur at baseline, at week 6, at week 13 and at week 18.4
Cognitive function
Participants' cognitive function will be examined through the Cognitive Telephone Screening Instrument and the Mini Mental State Examination.
Time frame
The assessment will be conducted at baseline, at week 6, at week 13 and at week 18.Secondary outcomes
1
SF-36 questionnaire
The SF-36 questionnaire is used to assess the participant's health status of participants. It consists of 36 items that assess physical functioning, physical performance, physical pain, emotional functioning, vitality, mental health, social functioning, and general health. The higher the score, the better the participant's health.
Time frame
The assessment will be conducted at baseline and at week 13 after the intervention end.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universidade da Madeira
Lead sponsor
Élvio Rúbio Gouveia
Collaborator
Hildegardo Noronha
Collaborator
Francisco Santos
Collaborator
Mara Dionísio
Collaborator
Eva Freitas
Collaborator
Pedro Campos
Collaborator
Paulo Bala
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: